Pharma Industary

Antibody therapeutics have made it possible to address the hard to target hotspots, rendering the domain of antibody discovery an emerging sector in the pharmaceutical industry; in fact, the antibodies have proven to be promising weapons in the battle against COVID-19 pandemic.

Roots Analysis is pleased to announce the publication of its recent study, titled, Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030.”

The report features an extensive study of the current market landscape, offering an informed opinion on the likely evolution in this industry over the next ten years. It features an in-depth analysis of the antibody discovery technologies and services that assist in the development of antibody therapeutics. In addition to other elements, the study includes:

 A detailed overview of the overall landscape of antibody discovery service providers along with the information on a number of relevant parameters.

 In the last five years, more than 400 agreements were inked related to antibody discovery, with the maximum activity being reported in 2018.

 An insightful competitiveness analysis of antibody discovery service providers based on various relevant parameters, such as supplier power and service portfolio specifications.

 Elaborate profiles of the prominent companies that provide antibody discovery services.

 A detailed review of the overall landscape of antibody discovery platforms, along with the information on the technology developers.

 An in-depth analysis of antibody discovery platforms, taking into consideration the supplier power and key technology specifications.

 Elaborate profiles of the companies providing antibody discovery technologies / platforms.

 An assessment of antibody discovery service and platform providers’ capability in different regions.

 An analysis of the partnerships that have been established in the period between 2015 and 2020.

 The licensing market opportunity for antibody discovery platforms is anticipated to grow at a CAGR of close to 10%, during 2020-2030

 An analysis of the investments made in this domain, during the period between 2016 and 2020 (till April), in companies that are engaged in the field of antibody drug discovery.

 Detailed profiles on the top five therapeutic antibody products, which have generated the highest revenues.

 A case study on antibody humanization and affinity maturation, highlighting key players, the ongoing research trends and the major challenges in this field.

 A detailed market forecast, featuring analysis of the financial opportunity within the antibody discovery services market across the following segments:

 Steps Involved in the Antibody Discovery Process

 Antigen Designing

 Hit Generation

 Lead Selection

 Lead Optimization

 Lead Characterization

 Antibody Discovery Method Used

 Phage Display

 Hybridoma

 Transgenic Animal

 Yeast Display

 Single Cell

 Others

 Nature of Antibody Generated

 Humanized

 Human

 Chimeric

 Murine

Press Release: Variation 1 (Format 2)

 Key Geographical Regions

 North America

 Europe

 Asia Pacific and Rest of the World

 A detailed market forecast, featuring analysis of the financial opportunity within the antibody discovery services market across the following segments:

 Type of Payment

 Upfront Payments

 Milestone Payments

 Key Geographical Regions

 North America

 Europe

 Asia Pacific

Key companies covered in the report:

 Abzena

 Abwiz Bio

 Aragen Bioscience

 BIOTEM

 ChemPartner

 Creative Biolabs

 Distributed Bio

 Harbour BioMed

 HD Biosciences

 ImmunoPrecise Antibodies

 Integral Molecular

 Kymab

 LakePharma

 Ligand Pharmaceuticals

 MorphoSys

 PX’Therapeutics

 Syd Labs

 Viva Biotech

 Wuxi Biologics

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html

Other recent offerings:

4. Antibody Contract Manufacturing Market, 2020 – 2030

5. Antibody Drug Conjugates Market (5th Edition), 2019-2030

6. Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market, 2019-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/